NCT00289861View on ClinicalTrials.gov

Risperidone Augmentation in Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Risperidone

DRUG

placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00289861 - Risperidone Augmentation in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter